Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Passage BIO, Inc.

NASDAQ: PASG · Life Sciences · 2 alerts · CIK 1787297

Share price
$4.13Close, Nov 16
Market cap
$13.3M
Shares outstanding
3.22MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Passage BIO, Inc. filings on SEC EDGAR ↗

7:16 AM ET 10-Q
Financial Results

Passage BIO Q3 2026 Results: Net Loss of $4.72M, Loss Narrows

Passage Bio reported a net loss of $20.1 million for the nine months ended September 30, 2026, as it began winding down its gene therapy programs and entered into a merger agreement. Total assets decreased significantly from $62.3 million at year-end 2025 to $20.8 million, primarily due to the reduction in cash and the termination of lease assets.

Key figure
Net loss $4.72M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.